Logo-joddd
Effect of Ferula persica plant methanol extract on the level of Cox-2 in induced squamous cell carcinoma (SCC) in rat tongue

J Dent Res Dent Clin Dent Prospects, 12(2), 91-96; DOI:10.15171/joddd.2018.014

Basic Research

Effect of Ferula persica plant methanol extract on the level of Cox-2 in induced squamous cell carcinoma (SCC) in rat tongue

Sepideh Vosoughhosseini1, Amirala Aghbali2, Parya Emamverdizadeh 3*, Mohammad Razbani4, Mehran Mesgari5, Ali Barzegar6

1 Professor, Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
2 Associate professor, Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
3 Assistant Professor, Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
4 Postgraduate Student, Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
5 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
6 Assistant Professor, Department of Community Nutrition, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran

*Corresponding Author; Email: emamiparya@yahoo.com

© 2018 by Tabriz University of Medical Sciences

Abstract

Background. More than 90% of oral cancers are cases of squamous cell carcinoma. Standard treatment of cancer includes a combination of surgery, chemotherapy and radiotherapy. Each of these treatments, however, brings about certain problems and side effects. Today herbal medicines have become a more preferable option in dealing with health problems or preventing them because they have better compatibility with the body and do not cause undesirable side effects. In this study, the effect of Ferula persica plant methanol extract on Cox-2 levels in SCC induced in rat tongue was evaluated in vivo.

Methods. In this experimental study, 75 rats from SD race in the age range of 2.5–3 months were selected and assigned to five groups. In order to induce tongue carcinoma, 4- nitroquinoline 1-oxide (4NQO) powder was used 3 times a week for each rat. Furthermore, Ferula persica extract was given to each group in order to examine Cox-2 changes in the blood.

Results. There were significant differences between the Cox-2 levels in the groups receiving the carcinogen only and the other groups. In this group, Cox-2 level was low and in the group receiving Ferula extract (500 mg) along with carcinogen, Cox-2 level was found to be higher than other groups.

Conclusion. Ferula persica extract did not decrease serum Cox-2 levels.

Keywords: Cox-2, ferula persica, squamous cell carcinoma

Introduction

Oral cancer is one of the most common neoplasms in the world. Various factors lead to oral cancers.1 More than 90% of oral cancers are cases of squamous cell carcinoma. This type of cancer has the highest mortality rate: almost half of the people suffering from it live more than 5 years after the onset of the disease.2,3 In various studies on the etiology of oral cancers, it has been observed that Cox-2 has high expression in oral cancers and precancerous lesions and it seems to be one of the agents involved in the etiology of oral lesions. Cox-2 is an enzyme produced by epithelial cells through stimulation by growth factors, cytokines and mitogens, and results in the production of prostaglandins in response to inflammation, proliferation, cellular differentiation, angiogenesis and metastasis. Increase in Cox-2 expression has been reported in cases of various tumors like colon, lung, bladder and hypopharynx. In recent studies, it has been found out that Cox-2 expression in precancerous lesions and oral cancers is significantly positive. Evidence indicates that use of Cox-2 inhibitors might be a promising method in the treatment of oral cancers.4-10

Standard treatment of cancers includes a combination of surgery, chemotherapy and radiotherapy. Each of these treatments has its own side effects and problems. Radiotherapy side effects include dry mouth, sensitivity of the gingivae and teeth, extensive dental caries and problems during swallowing. Chemotherapy side effects are irritation of the mouth or throat, weight loss, thrombocytopenia, infection, nausea, vomiting, loss of appetite and diarrhea. Patients who are in advanced stages of the condition and undergo surgery might suffer from speech disorders, chewing or swallowing problems or facial deformity.3

Today in most countries of the world, traditional medicine, especially herbal medicine, is used to prevent or cure diseases. It seems that people are tired of insufficiencies of modern medicine; so they increasingly turn to herbal medicine.11

Due to their non-artificial nature and existence of medicinal homologous compounds, traditional medicines have better compatibility with the body; moreover, they do not usually have undesirable side effects. Therefore, these medicines can be useful, particularly in cases when drug use will be prolonged and in chronic diseases.12,13 Furthermore, these natural compounds contain antioxidants which are capable of combating cancerous cells. 11

Antioxidants protect the body against damage, especially free radicals, and prevent the growth of cancerous cells.3 One of the herbs used in conventional medicine is Ferula persica. It belongs to Umbelliferae family and has 150 varieties all over Asia and Iran.14

In traditional medicine, the resin and gum of this plant is used as an expectorant, anti-swelling, anti-bloat, and laxative. Also, it is a cure for neurological disorders, epilepsy and various pains, especially arthralgias.15,16 In addition, studies have shown that most Ferula varieties have anti-cancerous and antioxidant activity through production of coumarin and umbelliprenin.17-24 In some in vitro studies, the anti-cancer effect of Ferula extract on cancer cell lines (leukemia, fibrosarcoma, melanoma and breast cancer) has been examined. Alkatib et al24 showed that elaeochytrin, a substance present in Ferula, is the most effective on human CML cell line (imatinib-resistant) and mice leukemia cell line (dasatinib-resistant), which were effective in densities of 12.4 and 7.8 μM, respectively.24

To date, the effect of this herbal extract has not been examined on oral cancers. In previous in vitro studies on the effect of this extract on other cancers, in vivo studies have been suggested for further evaluations.22 Since Cox-2 has high expression in cancer and in precancerous lesions of the oral cavity and is an effective agent in carcinogenesis and its inhibitors are considered to be a promising method for cancer` treatment, in this study the effect of methanolic extract of Ferula persica on Cox-2 levels in SCC induced in rat tongue was evaluated in vivo for the first time. The results of this study can be used in future research on the etiology, prevention and better treatment – with little side effects – for SCC, the most common type of oral cancer.

Materials and Methods

Sample selection and drug prescription method

In this experimental study, based on previous studies, 75 rats (5 groups of 15 rats) of SD race with an age range of 2.5‒3 months and an approximate weight of 200±50 gr were used at a temperature of 22±2°C, 12-hour light cycles and 60±5% humidity.25-29 Rats without these prerequisites were excluded from the study. Based on available literature, in order to induce tongue carcinoma, 4-nitroquinolin1-oxide (4NQO) powder (Sigma Co., Germany) was used.10

In this study, Ferula persica extract was injected to the rats groups A, B, and C. The extract was dissolved in distilled water with different densities of 50, 250 and 500 mg/kg. The carcinogen 4-nitroquinolin -oxide (4NQO) was orally given to rats at the same time. The 4th group, group D, only received the carcinogen and the 5th group, group E, only received the extract through injection in order to study the possible side effects of Ferula persica.

Preparation of Ferula persica water extract

This plant was obtained from Khalkhal highlands in Ardebil Province, Iran, and after being checked and verified by the expert in Drug Applied Research Center of Tabriz University of Medical Sciences, it was extracted through Soxhlet extraction method. Since in most of the previous studies, hydroalchoholic extracts of Ferula variety plants have been used, the same extract was prepared in this study. To this end, stems, leaves and flowers of this plant were dried at room temperature and then ground to obtain the dry powder. Then its methanolichydroalchoholic extract was prepared through Soxhlet method. The resultant solution was condensed by rotary vacuum evaporator and finally dried on a water bath at a mild temperature of 40°C. The desired density was then prepared from the extract.25,26 This was done by solving 500 mg of dry matter in 50 mL of distilled water. Of this solution, 5 milliliter per each kg weight of animal was injected into the animal through intraperitoneal injection (50mg/kg dose); 250 and 500 mg/kg doses were also prepared through dilution with distilled water while paying attention to the results of previous studies that at doses higher than 500 mg/kg motor deficits were observed in rotarod test.,30 At the end of the three-month research period, blood test of the mice was carried out; blood serum was separated and the concentration of Cox-2 of the groups was measured by ELISA method(Figure1).

Blood samples of the mice.

Finally, the results were analyzed through Kruskal-Wallis test and Mann-Whitney U test in order to compare Cox-2 levels between different groups.

Ethical considerations

All the ethical and the humanity considerations were considered and performed according to the Helsinki Declaration during the experiments and euthanasia of the animals. All the animal experiments were approved by the Ethics Committee of the Tabriz University of Medical Sciences.

Results

In this study, 75 rats (5 groups of 15 rats) of SD race were used; 50,250 and 500 mg/kg concentrations of Ferula persica extract dissolved in distilled water were injected through an intraperitoneal technique to the mice groups A, B and C. Carcinogen 4NQO was given orally to the mice at the same time. Group D mice only received carcinogen and group E, received only Ferula persica extract in order to study the possible side effects. At the end of the study, biopsies were taken from the rat tongues and the degree of dysplasia in each group was determined. Statistical analysis showed significant differences between groups (P<0.001). Use of Ferula persica extract resulted in recovery in groups A, B and C (Table 1).

Table 1.Degree of dysplasia in groups A, B, C and D
Group Type of lesion Total
No. (%)
Mild Dysplasia
No. (%)
Moderate Dysplasia
No. (%)
Severe Dysplasia
No. (%)
Carcinoma in situ
No. (%)
OSCC
No. (%)
A 2 (16.6) 4 (33.3) 3 (25) 1 (8.5) 2 (16.6) 12 (100)
B 3 (25) 2 (16.6) 4 (33.3) 2 (16.6) 1 (8.5) 12 (100)
C 2 (18.1) 4 (36.3) 3 (27.2) 1 (9.2) 1 (9.2) 11 (100)
D 0 (0.0) 0 (0.0) 0 (0.0) 2 (28.5) 5 (71.5) 7 (100)
Total 7 (16.6) 10 (23.8) 10 (23.8) 6 (14.2) 9 (21.6) 42 (100)

The outcomes of animals that survived up to the end of the study were separately presented for groups. Average Cox-2 level in each group is presented in the following Table. Cox-2 mean in group C was higher than that in other groups while in group D, it was lower compared to the other groups.

In order to compare Cox-2 means between various groups, Kruskal-Wallis test was used. This test showed significant differences in Cox-2 means between various groups (P=0.038). Comparison of Cox-2 in different groups showed significant differences in Cox-2 levels between group D and other groups (in group D, it was lower and in group C, it was higher than that in other groups) (Table 2).

Table 2.Cox-2 levels in groups A , B , C, D and E
Group Number Mean of Cox-2 Std. Deviation Minimum Maximum
A 12 303.083 28.1141 247.5 363.5
B 12 297.917 27.4589 250.0 337.0
C 11 313.364 26.8133 277.0 351.0
D 7 247.214 26.2645 215.0 284.0
E 9 305.500 17.4428 274.0 329.5
Total 51 296.843 32.2954 215.0 363.5

Discussion

Today, in many countries traditional medicine, especially herbal medicine, is used to either prevent or cure diseases. These compounds contain antioxidants, which are capable of fighting cancer cells. One of the plants used for this purpose is Ferula persica whose antineoplastic effects have been shown in various studies.

In our study, statistical analyses indicated significant differences among the study groups(P<0.001). Following the use of Ferula persica extract, recovery was seen in groups A, B and C, a fact which is consistent with other studies in this field. Research has shown that due to production of coumarin and umbelliprenin, most Ferula varieties have anti-cancer effects and antioxidant activity.23,24 Through a series of in vitro studies, anti-cancer effects of Ferula extract on cancer cell lines (leukemia, fibrosarcoma, melanoma and breast cancer) has been studied. Alkatib et al reported that elaeochytrin which a compound in Ferula plants has the most cytotoxic effect on human CML cell line and mouse leukemia cell line.24

In various studies on oral cancer etiology, it has been observed that Cox-2 is highly expressed in oral cancer and precancerous lesions and it seems that Cox-2 is an agent that plays a role in the etiology of oral lesions.7-11

In a study by Arbabi et al on rats suffering from tongue carcinoma, Cox-2 levels increased in blood of rats receiving the carcinogen; topical application of CeleCoxib, Cox-2 selective inhibitor, decreased its level in blood and was therefore considered an adjunct treatment for malignant lesions.31

In another study on patients suffering from hypopharyngeal SCC, Ping Pen et al concluded that Cox-2 serum levels increased in these patients and suggested that use of certain Cox-2 inhibitors might be effective in such patients.8

Considering these findings in relation to anti-cancer activity of Ferula and an increase in Cox-2levels in oral cancer, our study focused on the effect of Ferula on Cox-2 enzyme.

Statistical tests showed significant differences in Cox-2 means of various groups (P=0.038). In group D, it was the lowest and in group C, it was the highest. Furthermore, this plant did not decrease Cox-2 levels.

In numerous studies, Ferula mechanism in cancer inhibition was examined. For example, in one study, farnesiferol A and galbanic acid extracted from Ferula plant inhibited p-glycoprotein transporter in breast cancer cell line resistant to doxorubicin.

Based on this result, they suggested that this plant be considered in studies on chemotherapy drugs for patients suffering from breast cancer resistant to treatment.32

In another study, unbelliprenin of Ferula plant had inhibitory effect on cell growth in M4Beu (pigmented malignant metastatic melanoma) through arresting cell cycle in G1 phase and inducing caspase-dependent apoptosis.33

In a study by Kim et al,34 galbanic acid extracted from Ferula plant resulted in the inhibition of angiogenesis as well as proliferation of tumor cells in lung cancer cell lines.

In addition, umbelliprenin and persicalsulphid extracted from Ferula persica with low dose have inhibitory effect on tumor cell invasion in fibrosarcoma cell line through inhibition of MMP.

It is suggested that this material be used as an anti-matrixmetalloproteinase in chemotherapy drugs.23

In this study, for the first time, the effect of Ferula persica plant was examined on Cox-2 level in squamous cell carcinoma (SCC) induced in rat tongue. Biopsy samples indicated that recovery was observed in groups receiving Ferula persica extract; statistical analyses showed that Ferula persica had no effect on decreasing Cox-2 levels.

Conclusion

According to the results of this animal research, Ferula persica extract did not decrease Cox-2 levels;therefore, it cannot act as a specific Cox-2 inhibitor. In any case, further studies are recommended in this field so that stronger results are obtained and possible anti-cancer mechanisms of Ferula persica become known.

Acknowledgments

This paper was extracted from the thesis No.189, and financially supported by the research council of the Tabriz University of Medical Sciences‏.

Authors’ contributions

SV, AA, PE, and MR contributed to the concept and the design of the study. MM contributed to the preparation of the extract. AB and MR contributed to the rat experiments. MR drafted the manuscript. All authors contributed to the critical revision of the manuscript, and have read and approved the final paper.

Funding

This study was funded by Tabriz University of Medical Sciences

Competing interests

The author declare no competing interests with regards to the authorship and/or publication of this article.

Ethics approval

This research was approved by the Ethics Committee of the Tabriz University of Medical Sciences.

References

  1. Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patient with oral cavity cancer. Jpn J Cli-nOncol 2004; 34(7): 379-385.doi:10.1093/jjco/hyh058. [Crossref]
  2. http://www.globocan.iarc.fr/DataSource_and_methods.asp.
  3. Petersen PE. Oral cancer prevention and control - The approach of the World Health Organization. Oral oncology 2008; 45(5):454-460.doi:10.1016/j.oraloncology.2008.05.023. [Crossref]
  4. Arima Y, NishigoriCh, Takeuchi T, Oka Sh, Morimoto K, Utani A, Miyachi Y. 4-Nitroquinoline 1-Oxide Forms 8-Hydroxydeoxyguanosine in Human Fibroblasts through Reactive Oxygen Species. Toxicological Sciences 2006; 91(2): 382–392.doi: 10.1093/toxsci/kfj161. [Crossref]
  5. Kitakawaa D, Cabrala L.A.G, Marquesb M.E.A., Salvadorib D.M.F, Ribeiro D.A. Medium-term tongue carcinogenesis assays: A comparative study between 4-nitroquinoline 1-oxide (4NQO)-induced rat and dimethylbenzanthracene (DMBA)-induced hamster car-cinogenesis. Journal of Experimental Animal Science 2006; 43: 219–227. doi:10.1016/j.jeas.2006.09.001. [Crossref]
  6. Vered M, Yarom N, Dayan D. 4NQO oral carcinogenesis: animal models, molecular markers and future expectations. Oral Oncology 2005; 41(4) : 337–339.doi: 10.1016/j.oraloncology.2004.07.005. [Crossref]
  7. Neville BW, Damm DD, Allen CM, et al. Oral and maxillofacial pathology, 3rd edition. USA, Saunders co; 2009.409-418.
  8. Peng JP, Su CY, Chang HC, et al. Overexpressionofcyclo-oxygenase 2 in squamous cell carcinomaof the hypopharynx. Hum Pathol 2002; 33(1): 100-104.doi:10.1053/hupa.2002.30187. [Crossref]
  9. Gallo O, Franchi A, Magnelli L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implica-tion tumor angiogenesis and metastasis.Neoplasia 2001; 3(1): 53-61. doi: 10.1038/sj/neo/7900127. [Crossref]
  10. Shiotani H, Denda A, Yamamoto K, et al. Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxideinduced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide1. Cancer Res 2001;61(4): 1451-6.doi: can-cerres.aacrjournals.org/content/61/4/1451. [Crossref]
  11. Shirahama T, Sakakura C. Overexpression of cyclo-oxygenase 2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 2001; 7(3):558-61.doi: clincancerres.aacrjournals.org/content/7/3/558. [Crossref]
  12. McGuire DB.Barriers and strategies in implementation of oral cancer standards for cancer patients. Supportive care in cancer 2003; 11(7): 435-441. doi: 10.1007/s00520-003-0466-4. [Crossref]
  13. AghbaliA, Moradi AbbasabadiF, DelazarA, Vosough HosseiniS, Zare ShahnehF, Baradaran B , JananiM. Induction of Apoptosis and Cytotoxic Activities of Iranian Orthodox Black Tea Extract (BTE)Using in vitro Models.Advanced Pharmaceutical Bulletin, 2014;4(3):255-260.doi:10.5681/apb.2014.037. [Crossref]
  14. Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Woolgar JA, et al. Advances and applications of oral cancer basic re-search. Oral Oncol2011; 47(9): 783-791.doi: 10.1016/j.oraloncology.2011.07.004. [Crossref]
  15. Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt I D, Pandey M K, ShishodiaSh Nair, M G. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Oncologic, Endocrine & Metabolic 2006; 10(1):87-118.doi:10.1517/14728222.10.1.87. [Crossref]
  16. MingMei Z, ZiQuan F, Wei J, AiHua Z. Integration of the holistic concept of traditional medicine and the partial character of modern medicine_applications of metabolomics in traditional chinese prescriptions research. Chinese Journal of Natural medicines 2009; 7(2): 95-100.doi: 10.3724/SP.J.1009.2009.00095. [Crossref]
  17. Hajimehdipoor H, Esmaeili S, Ramezani A, Jafari-Anaraki M, Mosaddegh M. The cytotoxic effect of Ferula persica var. Persica and Ferula Hezarlalehzarica against HepG2, A549, HT29, MCF7, and MDBK cell lines. Iranian Journal of Pharmaceutical Sciences 2012; 8(2): 115-119.
  18. SamsamShariat S.H. Extraction of effective substances of medicinal plants. 2end edition . Isfahan ,Mani Publications ; 2007. 3-56 ..
  19. Ahvazi M, Khalighi-Sigaroodi F, Charkhchiyan M, Mojab F, Mozaffariane VA, Zakeri H. Introduction of medicinal plants species with the most traditional usage in alamut region. Iranian Journal of Pharmaceutical Research (2012); 11 (1): 185-194.doi: http://www.ijpr.ir. [Crossref]
  20. Vafaei AA, Sajadi AA, Taherian AA, EmamiAbarghouei M, MiladiGorji H, Jarrahi M. The effect of Ferula Persica on modulation of withdrawal syndrome sign in morphine dependent mice.Iran J Pharm Res 2004; 3(1): 72-72.
  21. Mandegary A, Sayyah M, Heidari MR. Antinociceptive and anti-inflammatory activity of the seed and root extracts of Ferula Gum-mosaBoiss in mice and rats. DARU 2004; 12(2): 58-62.
  22. Javidnia K, Miri R, Kamalinejad M, Edraki N. Chemical composition of Ferula persica Wild. essential oil from Iran. Flavour and Fra-grance Journal 2005; 20(6): 605–606.doi: 10.1002/ffj.1496. [Crossref]
  23. Shahverdi AR, Saadat F, Khorramizadeh MR, Iranshahi M, Kkoshayand MR. Two matrix metalloproteinases inhibitors from ferula persicavar . Phytomedicine2006; 13(10): 712-717.doi: 10.1016/j.phymed.2006.01.003. [Crossref]
  24. Alkhatib R, Hennebelle T, Joha S, Idziorek T, Preudhomme C, Quesnel B, et al. Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell lines. Phytochemistry2008; 69(17): 2979-2983.doi: 10.1016/j.phytochem. [Crossref]
  25. Jadidi M, Vafaei A, Miladi H, Babaei A. The effect of ferula persica extracts (Sakbinag) on symptoms of morphine withdrawal and sleeping time in mice.Pajouheshdarpezeshki 2010; 34(4):225-230.
  26. Ghanbari M, ZahediM ,VakiliA , Taherian A, Sameni H. Acute and chronic effects of aqueous Ferula persica extract on blood pressure of normotensive rats.Koomesh 2012; 45 (1):104-108.
  27. Masoumeh Mehdipour, Ali Taghavi Zenooz, Azin Sohrabi, Narges Gholizadeh, Ayla Bahramian, and Zahra Jamali. A comparison of the effect of triamcinolone ointment and mouthwash with or without zinc on the healing process of aphthous stomatitis lesions. J Dent Res Dent Clin Dent Prospects. 2016 Spring; 10(2): 87–91. doi: 10.15171/joddd.2016.014. [Crossref]
  28. Hedayati M, Pouraboli I, MemarianR . Effect of the methanol extract of Otostegiapersica (Golder) on serum level of glucose and kidney function factors in streptozotocin induced diabetic male rats. Zahedan J Res Med Sci (ZJRMS) 2012; 14(1): 9-15.
  29. Sohrabi M,Soleimani J, Roshangar L, Vatansever S, Arbabi F, Khaki AA, et al. The effect of dietary and topical celecoxib on 4-Nitroquinoline-1-oxide-induced lingual epithelium alterations in rat.J Pak Med Assoc 2009; 11(59): 769-774.
  30. Sayyah M, Mandgary A. Anticonvulsant effect of Ferula gummosaBoiss root against experimental seizures. Iran Biomed J 2003; 7(3): 139-143.
  31. Arbabi- KalatiF, Mesgari M, Akbari N. Evaluation the effect of topical and systemic celecoxib on serum antioxidant in induction of tongue neoplasm in rat. J Zahedan Medical Sciences 2012;12(4): 11-16.
  32. Hanafi-Bojd MY, Iranshahi M, Mosaffa F, Tehrani SO, Kalalinia F, Behravan J. Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines.Planta Med. 2011 Sep;77(14):1590-3. doi: 10.1055/s-0030-1270987. [Crossref]
  33. Barthomeufa C, Lima S, Iranshahib M, Chollet P. Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu meta-static pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis. Phytomedi-cine2008; 15(2): 103–111.doi: 10.1016/j.phymed.2007.04.001. [Crossref]
  34. Kim K, Lee H, Jeong S, Lee E, et al. Galbanic acid isolated from ferula assafoetida Exerts In Vivo Anti-tumor Activity in association with Anti-angiogenesis and anti-proliferation. Pharm res 2011; 28: 597 – 609.doi: 10.1007/s11095-010-0311-7. [Crossref]
Submitted: 03 Sep 2017
Revised: 05 Mar 2018
Accepted: 19 May 2018
First published online: 27 Jun 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract View: 1763
PDF Download: 1191
Full Text View: 849